• EN

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    Does Stronger EPS, Higher 2026 Targets, and Bigger Buybacks Change The Bull Case For Encompass Health (EHC)?

    Simply Wall St·09/06/2026 07:23:56
    Listen to the news
    • In the past quarter, Encompass Health reported adjusted earnings per share of US$1.55, raised its 2026 outlook, expanded its share repurchase authorization to US$1.00 billion, paid a quarterly dividend, and outlined plans to open new hospitals and add beds.
    • This combination of stronger profitability, increased capital returns, and capacity expansion signals management’s confidence in the business and its long-term demand profile.
    • Now we’ll examine how the upgraded 2026 outlook and enlarged buyback program influence Encompass Health’s existing investment narrative.

    Outshine the giants: these 19 early-stage AI stocks could fund your retirement.

    Encompass Health Investment Narrative Recap

    To own Encompass Health, you need to believe inpatient rehabilitation will remain essential as the population ages and medically complex cases grow, and that the company can translate that demand into steady, efficient growth. The latest earnings beat and 2026 outlook raise support that thesis, but they do not materially change the main near term swing factors: execution on new hospital openings as a positive catalyst and persistent labor shortages as a key risk.

    Among the recent announcements, the expanded US$1.00 billion share repurchase authorization stands out, because it amplifies the near term impact of any improvement in earnings and cash generation tied to new hospitals and added beds. If those growth projects scale as intended while buybacks continue, the combined effect on per share metrics could become a central part of how investors frame the story relative to both the catalysts and the ongoing cost pressures around staffing.

    Yet despite the stronger outlook, investors still need to consider the risk that persistent labor shortages could...

    Read the full narrative on Encompass Health (it's free!)

    Encompass Health's narrative projects $7.9 billion revenue and $806.1 million earnings by 2029.

    Uncover how Encompass Health's forecasts yield a $148.17 fair value, a 22% upside to its current price.

    Exploring Other Perspectives

    EHC 1-Year Stock Price Chart
    EHC 1-Year Stock Price Chart

    Four fair value estimates from the Simply Wall St Community span roughly US$99 to US$148 per share, showing how far apart individual views can be. You can weigh those opinions against the recent outlook raise and capacity expansion plans to judge how potential growth might balance against the labor, reimbursement and execution risks discussed above.

    Explore 4 other fair value estimates on Encompass Health - why the stock might be worth as much as 22% more than the current price!

    The Verdict Is Yours

    Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

    Ready To Venture Into Other Investment Styles?

    Every day counts. These free picks are already gaining attention. See them before the crowd does:

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.